Fact CheckerSign in

NCT05974306Not yet recruiting

Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System

Evaluation of a Proactive Clinical Management and Early Diagnosis of Arrhythmias in Patients With Heart Failure and Non Severely Reduced Left Ventricular Function Through a Telemonitoring System: a Prospective Randomized Clinical Trial (VASCO)

Source: ClinicalTrials.gov · Last updated 3 Aug 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Vasco trial is a no profit, multicenter, international, prospective, randomized study designed to evaluate the clinical benefits of a remote monitoring management based on ILR vs standard practice in patients with high risk of cardiac arrhythmias, heart failure and left ventricle ejection fraction (LVEF)\> 40% .The study will enroll about 331 patients (221 in the ILR group and 110 in the in-hospital follow-up group).

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
331 (estimated)
First submitted
14 Jun 2023
Start date
1 Sept 2023
Primary completion date
1 Jun 2024
Lead sponsor
Leonardo Calò, MD
NCT number
NCT05974306

What you commit to

  • Study type: Interventional
  • Planned participants: 331
  • From 1 Sept 2023 to the primary completion date, 1 Jun 2024
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Cardiovascular events / myocardial revascularization in the previous three months

Other illness

  • Presence of other recognized indications to ILR (Unexplained syncope, cryptogenic stroke/TIA, Transient loss of consciousness and recurrent falls)

Other

  • Subject who is, or is expected to be unavailable for follow-up
  • Pregnancy
  • Medical contraindications for ILR implantation
  • Patients with PMK / ICD or with Indication for ICD / PMK implantation
  • Patients already on oral anticoagulant treatment
  • Patients who do not want to use the telemonitoring system

Who the study is looking for

  • Patients with heart failure, LVEF\> 40% who report episodes of palpitations.
  • Over 18 years of age
  • Ability to provide informed consent for registry participation and be willing and able to comply with the protocol described evaluations

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.